For type 1 diabetes patients, daily insulin injections are a lifelong commitment. But these patients may soon be able to better manage their disease with the help of a medication used to treat psoriasis.
A new study from Indiana University found that the medication Alefacept decreased insulin requirements in patients newly diagnosed with type 1 diabetes. This medication also helped preserve function in pancreatic beta cells for up to two years. Beta cells secrete insulin (the hormone which regulates blood sugar).
A secondary benefit of Alefacept was that patients who took it needed less insulin. They were also less likely to develop severe low blood sugar, called hypoglycemia, a common complication of diabetes. Speak to your doctor about new treatments available.